Updated Jul 16, 2026
Presti Mariyamma Varghese has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Presti Mariyamma Varghese is identified as a Director of OptimizeRx Corp in U.S. Securities and Exchange Commission filings, with the most recent filing dated June 10, 2026. The available context confirms a governance role at OptimizeRx Corp but does not provide additional public biographical detail within this context.
| Role | Director |
|---|---|
| Notability | 45/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-10 | OPRX | OptimizeRx Corp | A — Grant or award | 13.1K | $0.00 |
Presti Mariyamma Varghese is identified as a Director of OptimizeRx Corp in U.S. Securities and Exchange Commission filings, with the most recent filing dated June 10, 2026. The available context confirms a governance role at OptimizeRx Corp but does not provide additional public biographical detail within this context.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Presti Mariyamma Varghese profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.